Eugenics after the Nazis? The Evolution of a Problematic Discipline
By Christos Konstantopoulos,
The Collector
| 04. 27. 2023
What is the first period that comes to mind when one hears the term “eugenics”? For many, the answer is obvious: the Nazi dictatorship in Germany (1933-1945). And for good reason. The Nazis were indeed outspoken proponents of eugenics, carrying out multiple eugenic policies, including the T-4 involuntary euthanization program and compulsory sterilizations. The aim? To uplift and “purify” the “Aryan race” by weeding out “undesirables” from the gene pool and increasing the number of those deemed to be of “sound” genetic material. Nevertheless, the obsession of popular culture with World War II has obscured an uncomfortable truth: the survival of eugenic ideas after the collapse of Nazism. Rather than ending abruptly, modern eugenics was gradually phased out and ingeniously re-invented, allowing it to survive past 1945.
Optimizing Mankind: Eugenics Before the Nazis
In her book Controlling Human Heredity, historian of genetics Diane Paul explains that manipulating human reproduction to optimize a population’s traits is an old idea. Utopian thinkers, such as Plato in the 4th century BCE, and Tommaso Campanella in the 17th century CE, frequently formulated such...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...